Neumora Therapeutics, Inc. — Form D

Neumora Therapeutics, Inc. of Watertown, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-03. The offering totals $474.4M, of which $474.4M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2023-01-03
• Form: D
• Accession: 0001567619-23-000019
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $474.4M
• Amount sold: $474.4M
• Investors: 124
• Date of first sale: 2020-09-08
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-469477

Issuer

• Name: Neumora Therapeutics, Inc.
• CIK: 0001885522
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 490 Arsenal Way, Suite 200, Watertown, MA, 02472
• Phone: (857) 760-0900

Officers, directors & promoters (11)

More

• CIK 1885522 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search